CDC. Centers for disease control and prevention. Hypertension prevalence in the U.S. | Million Hearts®. 2023. Available from: https://millionhearts.hhs.gov/data-reports/hypertension-prevalence.html. Accessed 19 Jun 2025

Ettehad D, Emdin CA, Kiran A, Anderson SG, Callender T, Emberson J, et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet. 2016;387(10022):957–67.

Article  PubMed  Google Scholar 

Burnier M, Egan BM. Adherence in hypertension. Circ Res. 2019;124(7):1124–40.

Article  CAS  PubMed  Google Scholar 

Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, et al. First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015;65(4):766–74.

Article  PubMed  Google Scholar 

Bhatt DL, Kandzari DE, O’Neill WW, D’Agostino R, Flack JM, Katzen BT, et al. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370(15):1393–401.

Article  CAS  PubMed  Google Scholar 

Voora R, Hinderliter AL. Modulation of sympathetic overactivity to treat resistant hypertension. Curr Hypertens Rep. 2018;20(11):92.

Article  PubMed  Google Scholar 

Esler M. Illusions of truths in the symplicity HTN-3 trial: generic design strengths but neuroscience failings. J Am Soc Hypertens. 2014;8(8):593–8.

Article  PubMed  Google Scholar 

Azizi M, Schmieder RE, Mahfoud F, Weber MA, Daemen J, Davies J, et al. Endovascular ultrasound renal denervation to treat hypertension (RADIANCE-HTN SOLO): a multicentre, international, single-blind, randomised, sham-controlled trial. Lancet. 2018;391(10137):2335–45.

Article  PubMed  Google Scholar 

Bhatt DL, Vaduganathan M, Kandzari DE, Leon MB, Rocha-Singh K, Townsend RR, et al. Long-term outcomes after catheter-based renal artery denervation for resistant hypertension: final follow-up of the randomised SYMPLICITY HTN-3 Trial. Lancet. 2022;400(10361):1405–16.

Article  PubMed  Google Scholar 

Kandzari DE, Kario K, Mahfoud F, Cohen SA, Pilcher G, Pocock S, et al. The SPYRAL HTN global clinical trial program: rationale and design for studies of renal denervation in the absence (SPYRAL HTN OFF-MED) and presence (SPYRAL HTN ON-MED) of antihypertensive medications. Am Heart J. 2016;171(1):82–91.

Article  PubMed  Google Scholar 

Mahfoud F, Kandzari DE, Kario K, Townsend RR, Weber MA, Schmieder RE, et al. Long-term efficacy and safety of renal denervation in the presence of antihypertensive drugs (SPYRAL HTN-ON MED): a randomised, sham-controlled trial. Lancet. 2022;399(10333):1401–10.

Article  CAS  PubMed  Google Scholar 

Vongpatanasin W, Addo T. The next chapter of renal denervation after US food and drug administration approval. Circulation. 2024;149(10):760–3.

Article  PubMed  Google Scholar 

Kandzari DE, Böhm M, Mahfoud F, Townsend RR, Weber MA, Pocock S, et al. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial. Lancet. 2018;391(10137):2346–55.

Article  PubMed  Google Scholar 

Azizi M, Sanghvi K, Saxena M, Gosse P, Reilly JP, Levy T, et al. Ultrasound renal denervation for hypertension resistant to a triple medication pill (RADIANCE-HTN TRIO): a randomised, multicentre, single-blind, sham-controlled trial. Lancet. 2021;397(10293):2476–86.

Article  CAS  PubMed  Google Scholar 

Böhm M, Kario K, Kandzari DE, Mahfoud F, Weber MA, Schmieder RE, et al. Efficacy of catheter-based renal denervation in the absence of antihypertensive medications (SPYRAL HTN-OFF MED Pivotal): a multicentre, randomised, sham-controlled trial. Lancet. 2020;395(10234):1444–51.

Article  PubMed  Google Scholar 

Azizi M, Daemen J, Lobo MD, Mahfoud F, Sharp ASP, Schmieder RE, et al. 12-month results from the unblinded phase of the RADIANCE-HTN SOLO trial of ultrasound renal denervation. JACC Cardiovasc Interv. 2020;13(24):2922–33.

Article  PubMed  Google Scholar 

Azizi M, Saxena M, Wang Y, Jenkins JS, Devireddy C, Rader F, et al. Endovascular ultrasound renal denervation to treat hypertension: the RADIANCE II randomized clinical trial. JAMA. 2023;329(8):651–61.

Article  PubMed  PubMed Central  Google Scholar 

Kandzari DE, Townsend RR, Kario K, Mahfoud F, Weber MA, Schmieder RE, et al. Safety and efficacy of renal denervation in patients taking antihypertensive medications. JACC. 2023;82(19):1809–23.

Article  CAS  PubMed  Google Scholar 

Townsend RR, Ferdinand KC, Kandzari DE, Kario K, Mahfoud F, Weber MA, et al. Impact of antihypertensive medication changes after renal denervation among different patient groups: SPYRAL HTN-ON MED. Hypertension. 2024;81(5):1095–105.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahfoud F, Mancia G, Schmieder RE, Ruilope L, Narkiewicz K, Schlaich M, et al. Outcomes following radiofrequency renal denervation according to antihypertensive medications: subgroup analysis of the global SYMPLICITY registry DEFINE. Hypertension. 2023;80(8):1759–70.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mahfoud F, Böhm M, Schmieder R, Narkiewicz K, Ewen S, Ruilope L, et al. Effects of renal denervation on kidney function and long-term outcomes: 3-year follow-up from the global SYMPLICITY registry. Eur Heart J. 2019;40(42):3474–82.

Article  PubMed  PubMed Central  Google Scholar 

CDC. Chronic Kidney Disease. Chronic kidney disease in the United States, 2023. 2024. Available from: https://www.cdc.gov/kidney-disease/php/data-research/index.html. Accessed 20 Jun 2025.

Bikbov B, Purcell CA, Levey AS, Smith M, Abdoli A, Abebe M, et al. Global, regional, and national burden of chronic kidney disease, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet. 2020;395(10225):709–33.

Article  Google Scholar 

Thomas G, Xie D, Chen HY, Anderson AH, Appel LJ, Bodana S, et al. Prevalence and prognostic significance of apparent treatment resistant hypertension in chronic kidney disease: report from the chronic renal insufficiency cohort study. Hypertension. 2016;67(2):387–96.

Article  CAS  PubMed  Google Scholar 

Campese VM, Kogosov E. Renal afferent denervation prevents hypertension in rats with chronic renal failure. Hypertension. 1995;25(4):878–82.

Article  CAS  PubMed  Google Scholar 

Mohammad AA, Nawar K, Binks O, Abdulla MH. Effects of renal denervation on kidney function in patients with chronic kidney disease: a systematic review and meta-analysis. J Hum Hypertens. 2024;38(1):29–44.

Article  PubMed  Google Scholar 

Xia M, Liu T, Chen D, Huang Y. Efficacy and safety of renal denervation for hypertension in patients with chronic kidney disease: a meta-analysis. Int J Hyperthermia. 2021;38(1):732–42.

Article  CAS  PubMed  Google Scholar 

Ott C, Mahfoud F, Mancia G, Narkiewicz K, Ruilope LM, Fahy M, et al. Renal denervation in patients with versus without chronic kidney disease: results from the global SYMPLICITY registry with follow-up data of 3 years. Nephrol Dial Transplant. 2022;37(2):304–10.

Article  PubMed  Google Scholar 

Ott C, Schmid A, Ditting T, Veelken R, Uder M, Schmieder RE. Effects of renal denervation on blood pressure in hypertensive patients with end-stage renal disease: a single centre experience. Clin Exp Nephrol. 2019;23(6):749–55.

Article  PubMed  Google Scholar 

Scalise F, Sole A, Singh G, Sorropago A, Sorropago G, Ballabeni C, et al. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis. J Hypertens. 2020;38(5):936.

Article  CAS  PubMed  Google Scholar 

Schlaich MP, Bart B, Hering D, Walton A, Marusic P, Mahfoud F, et al. Feasibility of catheter-based renal nerve ablation and effects on sympathetic nerve activity and blood pressure in patients with end-stage renal disease. Int J Cardiol. 2013;168(3):2214–20.

Article  PubMed  Google Scholar 

Mahfoud F, Azizi M, Daemen J, Sharp ASP, Patak A, Iglesias JF, et al. Real-world experience with ultrasound renal denervation utilizing home blood pressure monitoring: the global paradise system registry study design. Clin Res Cardiol. 2024;113(10):1375–83.

PubMed  Google Scholar 

Writing Committee Members*, Jones DW, Ferdinand KC, Taler SJ, Johnson HM, Shimbo D, et al. AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM guideline for the prevention, detection, evaluation and management of high blood pressure in adults: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Hypertens Dallas Tex 1979. 2025;82(10):e212-316.